Study explores potential antiviral treatment approach for Long Covid

a scientific impression of the human lungs
Image provided by Getty.

Researchers from Loughborough University have reported encouraging results from a new clinical trial looking to find a potential treatment for Long Covid.

The £1.2m trial, led by the University of Derby, Loughborough University and managed by the University of Plymouth's Peninsula Clinical Trials Unit, explored whether an antiviral drug delivered intravenously could be used to treat people with Long Covid.

The study found that delivering a five-day intravenous treatment and carrying out the assessments needed to evaluate it in people with Long Covid was safe and feasible.

While the project was established to test the feasibility of using intravenous medications, researchers reported a number of encouraging changes in exploratory outcome measures, with most participants reporting reductions in fatigue, improved quality of life and increased walking distance in a timed walking test.

Now the research team is calling for a larger randomised controlled trial to establish whether the antiviral treatment is effective for people with Long Covid.

The research, which tested 73 patients, found:

  • The five-day intravenous treatment regimen could be successfully delivered
  • Participants were able to complete the clinical assessments required for the research
  • The study generated important information needed to plan a larger randomised controlled trial

More than two million people in the UK have been estimated to be living with Long Covid. Symptoms can vary considerably and include extreme fatigue, breathlessness, palpitations and brain fog.

Professor Mark Faghy, Visiting Professor at the University of Derby and Professor of Clinical Exercise Science at Loughborough University, who led the study, said:

“These findings are an important step forward in our research into potential treatments for Long Covid. We have shown that it is possible to deliver this intravenous antiviral treatment and undertake the assessments needed to evaluate it in people with Long Covid.

“We also saw encouraging changes in measures including fatigue, functional capacity, quality of life and commonly reported symptoms. While ERASE was not designed to tell us whether the treatment caused those changes or whether the treatment works, the findings give us a strong rationale for carrying out a larger randomised controlled trial that will allow us to answer that question.

“We have worked closely with our research partners and patients throughout the study and have seen first-hand the considerable impact Long Covid can have on people’s lives. The next step is to build on what we have learned and rigorously test whether this approach can benefit patients.”

The ERASE trial began in September 2024, five years on from the start of the pandemic, as part of a wider programme of ground-breaking research led by the University of Derby into the causes and impacts of Long Covid.

73 patients underwent a series of assessments at the University's specialist facilities, and at the University of Exeter, before receiving the antiviral drug intravenously for five consecutive days by clinical teams from University Hospitals of Derby and Burton NHS Foundation Trust (UHDB) and Royal Devon University Healthcare NHS Foundation Trust and in collaboration with Aston University.

Dr Tom Bewick, who was the Principal Investigator for UHDB on this study, said: "We are proud to participate in the ERASE-Long Covid study in which over 50 long Covid sufferers in Derbyshire were selected to receive a five-day course of antiviral treatment at the Royal Derby Hospital. Following the successful delivery of this pilot, it is the goal to expand this research in the future in a larger randomised trial." 

Professor David Strain, from the University of Exeter, Clinician and study co-author, said: “We’re still seeing large numbers of people who are debilitated by Long Covid in clinic. Our study is a promising step to indicate that the specific antiviral we tested may offer some relief to symptoms, though we now need confirmation in much larger clinical trials to evaluate how effective it is. Our advice to people with long Covid remains to talk to your GP and follow clinical guidance.”

Over the past four years, researchers at the University of Derby, with their collaborators, have conducted a series of award-winning international studies to explore the causes and impacts of acute SARS-CoV-2 infection and Long Covid. The researchers have looked to understand the causes and contributing factors of the condition by bringing clinical insight together with the lived experience of patients.

Press Release Reference: 26/270

Loughborough is one of the country’s leading universities, with an international reputation for research that matters, excellence in teaching, strong links with industry, and unrivalled achievement in sport and its underpinning academic disciplines.

It has been awarded five stars in the independent QS Stars university rating scheme and named the best university in the world for sports-related subjects in the 2026 QS World University Rankings – the tenth-year running.

Loughborough has been ranked eighth in the Complete University Guide 2027 – out of 130 institutions. The achievement means Loughborough remains among a select group of universities that have maintained a top 10 position for more than 10 consecutive years, alongside Oxford, Cambridge, the London School of Economics, St Andrews, Durham and Imperial.

The University also ranked 9th in the Guardian University Guide 2027, out of 123 institutions nationwide and was named University of the Year for Sport in the Times and Sunday Times Good University Guide 2025 - the fourth time it has been awarded the prestigious title.

In the Research Excellence Framework (REF) 2021 over 90% of its research was rated as ‘world-leading’ or ‘internationally-excellent’. In recognition of its contribution to the sector, Loughborough has been awarded eight Queen Elizabeth Prizes for Higher and Further Education.

The Loughborough University London campus is based on the Queen Elizabeth Olympic Park and offers postgraduate and executive-level education, as well as research and enterprise opportunities. It is home to influential thought leaders, pioneering researchers and creative innovators who provide students with the highest quality of teaching and the very latest in modern thinking. 

--

The University of Derby is an ambitious, industry-connected, civic university based in the heart of England, recognised for excellent teaching, applied research and strong outcomes for students.  

Derby is the Uni Compare UK University of the Year for 2027, ranked first for employability, second for accommodation and second for course quality. 97% of students who submitted reviews for Derby said they would recommend the University to a friend.  

The institution was awarded Gold in the Teaching Excellence Framework (TEF) 2023, highlighting high-quality student experience and outcomes.  

Its academic provision is shaped by close collaboration with employers and professional bodies, ensuring students develop the knowledge, skills and experience required for successful careers. The University works closely with national and global partners, including Rolls-Royce, Toyota, the NHS and others, to embed industry engagement across learning and research.  

In 2025, the University opened the Cavendish Building, the new home of Derby International Business School, located in the city centre. The landmark development also hosts the University’s Institute of Carbonomics, created in collaboration with Intercontinental Exchange (ICE) and McDonald’s UK & Ireland. The Institute is designed to accelerate innovation in carbon economics, transform supply chain practices, and drive measurable, real-world solutions that deliver carbon reduction at scale. 

The University offers a wide range of traditional degrees, apprenticeships and professional development programmes, with a strong emphasis on employability and lifelong learning. Its curriculum and partnerships are designed to respond to evolving global and regional needs, including innovation, sustainability and social impact.  

As a civic university, Derby works in partnership with industry, public services, communities and cultural organisations to create opportunities, share knowledge and deliver positive change. The University currently holds a Bronze NCCPE Watermark, recognising its commitment to embedding public engagement across teaching, research and civic activity.

Through collaboration with city and regional partners, including its role in Derby’s membership of the UNESCO Global Network of Learning Cities and the National Saturday Club, the University is committed to widening participation, enhancing social mobility and supporting economic growth locally and internationally.